MENU
NXTS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nexentis Technologies (NXTS) Ownership - Who owns Nexentis Technologies?

Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways... Show more

Profile

Industry
N/A
Address
Pinhas Sapir Street 3
Phone
+972 3474689583
Employees
9
Web
https://nexentistech.com

Details

Group
Domestic Stock Funds
Category
Process Industries
Capitalization
2.13M
P/E Ratio
0.08
Total Cash
8.88M
Projected Growth
N/A
Total Debt
426K
Revenue
N/A
Risk (Beta)
2.62
Dividend Yield
N/A
Total Cash/Share
6.11
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns Nexentis Technologies? NXTS symbol Ownership - Tickeron.com